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THE MAJOR EPICARDIAL CORONARY arteries of the heart, unlike resistance vessels, are generally reported to remain quiescent following stretch when the endothelium is intact (17) . However, recently we have found that either mechanical removal of the endothelium or addition of the NO synthase (NOS) inhibitor N -nitro-L-arginine (L-NNA) to endothelium-intact coronary arteries leads to active tone development. A similar phenomenon has been reported for the main coronary arteries of the rat (19) . Little is known about the mechanisms underlying this active tone in larger coronary vessels.
Myogenic tone in microvessels has been studied extensively, and it has been linked to both increased L-type calcium channel (Ca v ) activity (34, 38, 45) and PKC activity (15, 21, 22, 26, 37, 39, 52, 64) . In the present study, we undertook experiments to examine the role of Ca v and PKC in active tone development in the coronary artery. Ca v is a voltage-dependent conductance that opens in response to membrane depolarization, leading to calcium entry and contraction. In contrast, PKC can cause contraction in the absence of a change in membrane potential (E m ) by increasing the sensitivity of the myofilaments to calcium (58) . However, the actions of PKC can also be linked to Ca v activity. For example, PKC can modify the activity of other ion channels that depolarize the membrane and therefore increase Ca v activity (16, 52) . Furthermore, PKC can have direct excitatory effects upon Ca v (6, 8, 55) . Thus the manner in which Ca v and PKC contribute to the regulation of active tone may be interdependent.
In this study, we have examined the hypothesis that active tone in the coronary artery is dependent on both PKC and Ca v activity and that PKC is linked to Ca v via changes in E m as well as direct effects of PKC on Ca v . To explore this hypothesis, contraction and E m were measured in intact segments of coronary artery and Ca v currents were measured in isolated myocytes by using the patch-clamp technique. Because little is known about active tone development in larger coronary arteries, initial studies characterized the dependence of active tone on endothelium-derived NO and stretch. In subsequent experiments, we addressed the role of Ca v and PKC by using a variety of pharmacological blockers and activators of PKC and Ca v . Because the direct effects of PKC on Ca v are predicted to increase the amount of calcium entry and contraction occurring at given level of E m , we also examined the relationship between E m and contraction in the presence and absence of active tone. Finally, the direct effects of PKC on Ca v currents were evaluated with the PKC activator phorbol dibutyrate (PDBu). Our results suggest that both PKC and Ca v contribute to active tone development in the rabbit coronary artery and that PKC may be linked to Ca v activity via both direct effects on the channel and indirect effects mediated via other channels that depolarize the membrane.
METHODS
Contractile experiments. Male albino rabbits (2.3-2.9 kg; Western Oregon Rabbitry, Philomath, OR) were killed with an overdose of 1 ml Euthasol solution (0.39 g pentobarbital sodium and 0.05 mg phenytoin sodium; Virbac AH, Fort Worth, Texas) injected into the ear vein via a protocol approved by the University Animal Care and Use committee. The left descending coronary artery and its main branches were dissected free and cleared of cardiac muscle and fat in ice-cold Krebs-Ringer bicarbonate solution (KRBS) of the following composition (in mM): 118.5 NaCl, 4.7 KCl, 1.2 MgCl 2, 23.8 NaHCO3, 1.2 KH2PO4, 11 dextrose, and 2.0 CaCl2, aerated with 95% O 2-5% CO2. Three-millimeter-long ring segments (400 -600 m) of coronary artery were then mounted on two triangles. The upper triangle was attached to a Gould strain gauge, and the lower triangle was attached to a stable mount. Vessels were immersed in tissue baths containing KRBS maintained at 37°C. In some experiments, 10 M indomethacin (cyclooxygenase pathway inhibitor) was also included in the KRBS solution. A resting tension of 0.5 g was initially applied to vessels. Vessels were restretched during the first hour of equilibration if passive stretch fell below this level. Unless otherwise specified, vessels were equilibrated for 2.5 h with 4-min exposures to the H 1 receptor agonist 2-(2-aminoethyl) pyridine (AEP; 30 M) added at 15-to 25-min intervals. The endothelium was removed in some experiments by gently rotating the vessel around the two triangles inserted through the lumen. The presence or absence of endothelium (Eϩ or EϪ, respectively) was evaluated by addition of bradykinin (10 nM) followed by substance P (100 nM). Both agonists were tested to ensure complete endothelium removal. Vessels were considered free of endothelium if no relaxation was obtained with either agonist. Contractile responses were normalized to the maximum contraction elicited with AEP (30 M) in combination with 90 mM KCl, whereas relaxations were normalized to the contraction preceding drug addition.
For experiments examining stretch, Eϩ vessels were equilibrated for 2.5 h as described above. After equilibration, passive tension was reduced from 0.5 g to a minimum level (i.e., ϳ0.05 g). This was followed by one of two protocols. In protocol 1, after 5 min L-NA (100 M) was added. After development of a stable level of active tone, vessels were stretched by applying 0.5 g of tension. In protocol 2, after 30 min vessels were stretched by applying 0.5 g of tension. In preliminary experiments on Eϩ vessels, we found that 0.5 g of applied tension was sufficient to produce a maximum response to 90 mM KCl, whereas when tension was reduced to 0.05 g, the response to 90 mM KCl was reduced to 45% of maximum.
Intracellular measurements of Em. For microelectrode measurements, 3-mm-long ring segments of coronary artery were mounted in a 2-ml bath superfused with KRBS and maintained at 37°C. The vessel was attached to a tension transducer via a triangle inserted through its lumen. A second wire was inserted through the vessel lumen and stably mounted to the base of the chamber. A resting tension of 0.5 g was applied to vessels. Vessels were equilibrated for 2 h followed by addition of combined AEP (30 M) and KCl (90 mM) to generate a maximum contraction. Experiments were begun 30 min after washing out this solution. Em was measured by using sharp microelectrodes with resistances ranging from 60 to 100 m⍀. Impalements were judged based on a rapid negative deflection from 0 mV following a tap, a stable level of potential while in the cell, and a rapid return to near the original 0-mV potential on removal of the electrode from the cell. It was generally not possible to maintain impalements during the onset of contraction or relaxation; thus several impalements were made during the control period and following establishment of a new condition. Em values for a given condition were averaged. An example of this approach is shown in RESULTS (see Fig. 6 ). Em was modified by either raising extracellular potassium concentration ([K]o) from 6 mM to 16 or 26 mM or by addition of pinacidil (0.3 M).
Isolation of coronary artery myocytes. Left and right descending coronary arteries were removed and cleared of cardiac muscle and fat in ice-cold KRBS aerated with 95% O2 and 5% CO2. Vessels were cut into small segments and placed in Ca 2ϩ -free Hanks' solution (in mM: 125 NaCl, 5.4 KCl, 15.5 NaHCO3, 0.34 Na2HPO4, 0.44 KH2PO4, 10 glucose, and 2.9 sucrose, aerated with 95% O2 and 5% CO2) for 30 min at 37°C. The segments were then transferred to Hanks' solution (0.1 mM Ca 2ϩ ) containing 1 mg/ml collagenase type I (Sigma, St. Louis, MO), 0.5 mg/ml protease type XXVII (Sigma), 2 mg/ml trypsin inhibitor (Sigma), 2 mg/ml BSA (Sigma), and 0.1 mg/ml ATP-Na2 and were incubated between 20 and 25 min with gentle agitation at 37°C, then rinsed four times with Hanks' solution (0.1 mM Ca 2ϩ ). After completion of the digestion, single cells were dispersed by gentle trituration of the segments with a wide-tipped fire-polished Pasteur pipette. The cell suspension was stored at 2°C in Hanks' solution (0.1 mM Ca 2ϩ ) containing 2 mg/ml trypsin inhibitor (Sigma) and 2 mg/ml BSA (Sigma) and was used within 6 h. Measurement of currents in isolated cells. Patch-clamp experiments were performed as previously described (6) . Inward Ca v currents were measured by using an Axopatch-1D patch-clamp amplifier, digitized with a 16-bit analog-to-digital converter (Digidata 1320A; Axon Instruments), and controlled by pClamp8 (Axon Instruments). Whole cell recordings were made by using the perforated-patch configuration. The bath solution used to record Ca v currents was composed of (in mM) 115 NaCl, 10 TEA Cl, 10 BaCl2, 0.5 MgCl2, 5.5 glucose, 5 CsCl, and 10 HEPES, pH 7.40, with NaOH. Both TEA Cl and CsCl were used to block potassium currents. The composition of the pipette solution was (in mM) 120 cesium aspartate, 20 TEA Cl, 1 EGTA, and 20 HEPES, adjusted to pH 7.2 with CsOH. Amphotericin B (90 mg/ml) was dissolved with DMSO, sonicated, and diluted to give a final concentration of 270 g/ml in the pipette solution.
Drugs.
-nitro-L-arginine methyl ester (L-NAME), collagenase type I, protease type XXVII, BSA, amphotericin B, PDBu, nifedipine, indomethacin, and pinacidil were purchased from Sigma. Chelerythrine Cl and Gö-6976 were from Calbiochem, and GF-109203X was from Tocris Cookson. 8-Bromo-2Ј-O-monobutyrylcAMPS, Rp isomer (Rp-8-Br MB-cAMPS) was from Biolog. Drugs insoluble in water were first dissolved in DMSO and were then additionally diluted so that the final concentration of DMSO was Ͻ0.2%. DMSO alone at 0.2% had no effect on Ca v currents or on a KCl contraction.
Statistics. Data are presented as means Ϯ SE. Means were compared by two-tailed paired or unpaired Student's t-test. A P value of Ͻ0.05 was considered significant. Concentration-response relationships were curve fit using GraphPad Prism 3.0 nonlinear regression analysis (GraphPad Software, San Diego, CA). Significant differences between curves were determined by using two-way ANOVA.
RESULTS

Active tone develops following blockade of endothelial NOS activity and is reversed when NO is reintroduced.
Eϩ rabbit coronary artery segments did not develop active tone throughout the duration of a 6-h experiment even when periodically stimulated with the histamine H 1 receptor agonist AEP (Fig. 1Aa) . However, in EϪ vessels, tone developed following 1.5-3 h of equilibration and persisted in spite of repeated washes of the vessel with fresh KRBS (Fig. 1Ab , n ϭ 17). Active tone also developed in EϪ vessels in which no contractile stimulus was added during the initial equilibration time (Fig. 1B) . Since NO is a well-established factor released from the endothelium, we examined whether tone could be generated in Eϩ vessels by inhibition of NOS activity. Addition of the selective endothelial/neuronal (e/nNOS) inhibitor L-NNA (100 M) to Eϩ vessels resulted in active tone development (Fig. 1C) , which averaged 30.1 Ϯ 3.2% of a maximum contraction (n ϭ 45), whereas the selective inducible NOS inhibitor L-NIL (100 M) was without effect (n ϭ 4) (5). Tone also developed with a second selective e/nNOS inhibitor, L-NAME (300 M, n ϭ 4) (5). The amplitude of active tone with L-NNA addition to Eϩ vessels was not significantly different from the active tone that Tension was reduced to a minimum (UnSt), and then L-NNA (100 M) was added, giving rise to a small increment in tone. Forty-five minutes later, stretch was reapplied (St) by increasing tension to 0.5 g. Stretch was followed by a brief active response, relaxation, and then more slowly developing tone. B: sample trace showing the lack of active tone development in a different Eϩ vessel in the absence of L-NNA. Subsequent addition of L-NNA to this vessel led to active tone development. (Note, L-NNA remains in bath following addition). C: tone that develops when L-NNA is added to vessels with minimum applied tension [Tone (no st); n ϭ 9] and following subsequent application of 0.5 g of tension (Total; n ϭ 8) as shown in A. Values are means Ϯ SE. For clarity, the components contributing to total force are shown, including active tone before stretch (light gray), applied force (black), and active tone after stretch (dark gray). Maximum force equals applied force plus the response to AEP (30 M) and KCl (90 mM). developed in EϪ vessels (37.1 Ϯ 3.6% maximum, n ϭ 17). Active tone also occurred with NOS blockade or in EϪ vessels when bathed with indomethacin (10 M, n ϭ 16), suggesting that tone was not due to generation of a cyclooxygenase product.
Because blocking NOS activity with L-NNA led to active tone development, we investigated whether tone could be reversed by addition of the NO donor SNP. Interestingly, active tone was reversed by nanomolar concentrations of SNP (IC 50 ϭ 9 nM) (Fig. 1D) .
Active tone enhances potassium-induced contractions and is abolished by pinacidil. The active tone that develops with addition of L-NNA was further investigated by depolarizing E m with high [K] o or by hyperpolarizing E m with the ATPsensitive potassium channel (K ATP ) opener pinacidil. The entire [K] o -vs.-contraction relationship, including the peak response, was shifted upward in vessels with L-NNA-induced tone, suggesting that an E m -independent process(s) contributes to active tone development ( Fig. 2A) . In contrast, tone was entirely reversed with pinacidil ( Fig. 2B ; IC 50 ϭ 33 nM), suggesting that an E m -dependent process(s) also contributes to active tone development. No further relaxation occurred when the KRBS was switched to a Ca 2ϩ -free 1 mM EGTA solution, suggesting that the remaining baseline tension was passive (0.48 Ϯ 0.03 vs. 0.46 Ϯ 0.03 g baseline tension before and after Ca 2ϩ -free solution, respectively; n ϭ 6).
Stretch elicits an active response following NOS blockade.
To examine whether stretch contributes to active tone development, we carried out experiments in which NOS activity was blocked before applying stretch to the tissue (see METHODS). Addition of L-NNA to minimally stretched vessels (ϳ0.05 g applied tension) gave rise to a small increment of active tone (Fig. 3A) . However, when tension was subsequently raised 30 -45 min later by 0.5 g, a significantly greater amount of active tone developed (Fig. 3A) . In contrast, when vessels were stretched by 0.5 g in the absence of L-NNA, tone did not develop, although subsequent addition of L-NNA generated active tone in these vessels (Fig. 3B) . The effects of stretch on L-NNA-induced tone are summarized in Fig. 3C .
PDBu-induced contractions and active tone are both reversed with nifedipine and PKC inhibitors. To investigate the role of PKC in active tone development, we first characterized the effects of the PKC activator PDBu. PDBu produced concentration-dependent contraction of tissues with an EC 50 of 7 nM (Fig. 4, A and B) . The rate at which contraction developed with low concentrations of PDBu was considerably slower than with higher concentrations of PDBu (Fig. 4, A and C) .
To determine the extent to which contractile responses elicited by stimulating PKC activity with PDBu resemble active tone development, we compared the pharmacology of these two types of contraction. The dihydropyridine Ca v blocker nifedipine (1 M) completely blocked L-NNA-induced active tone as well as the response to a low concentration of PDBu (10 nM) ( Fig. 4D ) with equal potency (IC 50 ϭ 9 nM) (Fig. 4E) . In contrast, the contraction elicited with a higher concentration of PDBu (300 nM) was only partially reversed with nifedipine (Fig. 4E) . Thus Ca v activity plays an important role in active tone and the response to 10 nM PDBu, whereas with higher PDBu concentrations other mechanisms, such as calcium sensitization (7, 33, 50) , play an increasingly greater role. Both chelerythrine and GF-109203X produced concentration-dependent inhibition of active tone and responses to PDBu (10 nM). There was no significant difference in the effects of either drug on active tone vs. PDBu responses (GF-109203X IC 50 ϭ 2.4 and 1.1 M, respectively; chelerythrine IC 50 ϭ 4.2 and 4.6 M, respectively) (Fig. 5, A and B) . Interestingly, both types of contraction were also blocked with equal potency by the classical PKC inhibitor Gö-6976 (IC 50 ϭ 0.4 and 0.3 M, respectively) (Fig. 5C) .
The relationship between E m and contraction is shifted to the left during active tone development and shifted back with chelerythrine or SNP. To evaluate the extent to which E m -dependent and -independent processes contribute to active tone generation, we measured E m as a function of contraction under various conditions. An example of several recordings made during active tone development is shown in Fig. 6A . Resting E m in control vessels averaged Ϫ56 Ϯ 0.8 mV (n ϭ 15). In the presence of L-NNA, E m was significantly depolarized compared with control and averaged Ϫ48 Ϯ 0.7 mV (n ϭ 29). Addition of either SNP (30 nM) or chelerythrine (10 M) in the presence of L-NNA repolarized cells to Ϫ52.5 Ϯ 0.8 mV (n ϭ 7) and Ϫ53.5 Ϯ 1.6 mV (n ϭ 8), respectively (Fig. 6B) .
To evaluate the relationship between E m and contraction in the presence and absence of tone, E m was varied by increasing [K] o from the control level (6 mM) up to 26 mM (Fig. 7A) . Figure 7B plots the E m -vs.-contraction relationships associated with the four conditions listed in Fig. 7A . This procedure revealed that the E m -vs.-contraction relationship was shifted to the left when basal NO release was blocked with L-NNA. For example, during control conditions when basal NO release was present, raising [K] o to 16 mM depolarized cells to Ϫ47.7 Ϯ 1.1 mV and caused very little contraction (6.0 Ϯ 2.5% maximum). In contrast, blocking NOS with L-NNA depolarized cells to the same extent (Ϫ48.1 Ϯ 0.7 mV) but gave rise to a significantly greater contraction (27.9 Ϯ 6.6% maximum) (Fig. 7B) . Interestingly, both SNP and chelerythrine shifted the E m -vs.-contraction relationship back toward the right. These data suggest that both NO and PKC contribute to the regulation of active tone and that both E m -dependent and E m -independent effects are involved.
Activation of PKC increases Ca v currents. The above experiments revealed that blockade of PKC with chelerythrine inhibited active tone and shifted the E m -vs.-contraction relationship to the right. Thus PKC contributes to active tone and acts in part via E m -independent mechanisms. One possible E m -independent mechanism is direct upregulation of Ca v activity by PKC. To explore this possibility, we recorded Ca v currents in coronary artery myocytes and examined the effects of the PKC activator PDBu. Currents were elicited by stepping voltage from a holding potential of Ϫ70 to 0 mV for 370 ms at 30-s intervals. PDBu at concentrations of 100 nM or greater gave rise to a significant increase in Ca v current. An example of the effect of PDBu on currents is shown in Fig. 8A , and the mean increase in current amplitude is plotted in Fig. 8B . The stimulation of currents with PDBu was reversed with either chelerythrine (1 M; Fig. 8C ) or Gö-6976 (200 nM; Fig. 8D ). PDBu (10 nM) did not produce a detectable increase in Ca v current. This result is not surprising given the extremely long time course required for development of the 10-nM PDBu response in isolated tissues (see Fig. 4) .
The NO donor SNP reduces Ca v currents when PKA is inhibited. In contrast to PKC, the NO-cGMP-PKG pathway causes inhibition of Ca v currents in various smooth muscles (1,  4, 9, 54) . Because removal or addition of NO also shifted the E m -vs.-contraction relationship, we reasoned that, like PKC, NO may have direct effects upon Ca v . However, concentrations of SNP up to 500 nM did not modify Ca v currents in isolated coronary artery myocytes. Because cGMP can also cross-activate PKA (49), we completed additional experiments examining the effects of SNP in the presence of the PKA blocker Rp-8-Br-MB-cAMPS (10 M). Inclusion of Rp-8-Br-MB-cAMPS in the superfusate did not significantly affect Ca v currents, but addition of 500 nM SNP in the presence of Rp-8-Br-MB-cAMPS now led to a 54% reduction of Ca v current amplitude, whereas 100 nM SNP was still without effect (Fig. 9) .
DISCUSSION
Active tone development in rabbit epicardial coronary arteries occurs when the ongoing release of NO from the endothelium is blocked. It is stretch sensitive and associated with both enhanced PKC and Ca v activity. In addition, several lines of evidence suggest that direct modulation of Ca v activity by PKC may contribute to active tone development in the coronary artery. These points are discussed individually below.
Role of NO in the regulation of active tone development. Endothelium-derived NO exerts a dilating influence that opposes arterial constriction in most vascular beds. The actions of NO are typically studied by applying drugs such as acetylcholine or bradykinin, which stimulate the synthesis and release of NO from the endothelium. However, NO is also released in vivo in response to shear stress (48) , and some studies (e.g., Ref. 27) report basal release of NO from the endothelium in the absence of either agonist stimulation or shear stress. In this study, we found that active tone developed in the rabbit coronary artery when NOS activity was blocked, indicating that spontaneous contraction was opposed by basal NO release. A similar relationship between basal NO release and active tone has been described for the main coronary arteries of the rat (19) and for the guinea pig spiral modiolar artery (27) . In the rabbit coronary artery, active tone was also reversed by very low concentrations of the NO donor SNP (IC 50 ϭ 9 nM), again suggesting that low background levels of NO can suppress active tone. These data all support the increasingly wellrecognized concept that ongoing release of NO from the endothelium significantly contributes to the regulation of vascular reactivity.
In this study, various experiments were undertaken to evaluate the mechanism(s) by which NO modulates tone. The major target of NO is guanylyl cyclase, which in turn generates cGMP, leading to activation of cGMP-dependent protein kinase (PKG) (41) . This pathway may cause smooth muscle relaxation via a variety of mechanisms, including 1) changes in ionic conductance that hyperpolarize E m , leading to closure of Ca v (19, 23, 44, 56, 63, 66) , 2) direct inhibition of Ca v (4, 9, 25, 42, 54), 3) decreased Ca 2ϩ sensitivity of the myofilaments (40, 61), 4) increased uptake of Ca 2ϩ into the sarcoplasmic reticulum (11, 14, 35) , and 5) suppression of PKC activity (29, 51, 53) . Because NO removal caused depolarization and NO addition caused repolarization, the actions of NO were likely to be due in part to changes in E m . Indeed, our observation that tone was entirely reversed by the K ATP channel opener pinacidil further supports the notion that active tone can be modulated by changes in E m . However, NO addition and removal also shifted the relationship between E m and contraction, suggesting that additional E m -independent mechanisms were involved as well. The fact that the maximum KCl-induced contraction was smaller when basal NO release was present also suggests that NO suppresses contraction in part via one or more E m -independent mechanisms (i.e., mechanisms 2-5).
To investigate the possible direct effects of NO on Ca v (mechanism 2) we undertook patch-clamp studies on isolated rabbit coronary artery myocytes. These studies revealed that even a high concentration of SNP (500 nM) was without effect on Ca v currents unless applied in the presence of a PKA inhibitor. Higher concentrations of cGMP can cross-activate PKA (3, 49, 62) , which in turn can enhance Ca v currents (see Ref. 30) . Thus blockade of PKA may reveal SNP-induced inhibition of Ca v current because it eliminates the opposing effects of cGMP on PKA. However, since both PKA blockade and 500 nM SNP were required to observe Ca v inhibition, our results do not provide a particularly compelling case for direct inhibition of Ca v by basally released NO in the rabbit coronary artery. Clearly, additional experiments are required to clarify this point.
Role of stretch in active tone development. The active tone characterized in this study was predominantly observed in stretched vessels. However, stretch alone was not sufficient to generate active tone when basal NO release was present. This suggests that two conditions are necessary for optimal tone development, i.e., 1) the absence of basal NO release and 2) stretch. A number of ionic conductances in vascular smooth muscle that can cause depolarization are stretch sensitive (55, 60) . In addition, stretch has been linked to PKC activation (64, 65) . Thus stretch may initiate changes in the vessel that predispose it toward tone development, whereas NO counterbalances these effects. This interplay of factors favoring and Fig. 10 . Some possible second-messenger pathways contributing to the regulation of coronary artery tone. Controlled targets in this scheme include Cav activity (bottom center) as well as myofilament sensitivity to Ca 2ϩ . The pathways depicted at left favor contraction, whereas those at right favor relaxation. There is evidence that PKC activity (possibly PKC-␣) is increased by stretch (64) (top left). In addition, constitutive PKC-␣ activity promotes clusters of Cav channels to operate in a persistent gating mode (46, 47) . In contrast, basal NO (top right) suppresses tone, and this action likely includes guanylyl cyclase and PKG. PKC and NO can indirectly affect Cav activity via changes in other ionic conductances such as potassium, chloride, and transient receptor potential channels (broken arrows) leading to either depolarization or hyperpolarization (see DISCUSSION) . In addition, our study provides evidence that Cav may be directly upregulated by a classical PKC. The stretched vessel with ongoing basal NO release is quiescent. However, when NOS activity is blocked, the balance shifts toward factors favoring contraction (left). Quiescence can then be restored either by addition of exogenous NO or alternatively by blocking PKC activity. Although not specifically addressed in this study, other pathways, such as Rho kinase (26, 28, 64) and the integrin/c-Src pathway (59) , are likely to contribute to this scheme as well. opposing contraction is discussed further in subsequent sections.
Interestingly, stretch did not cause active tone development immediately following immersion of EϪ vessels in warm KRBS (e.g., Fig. 1B) . The absence of an initial stretch response was likely due to recovery of the vessel following dissection in cold KRBS. Sodium pump activity is temperature dependent, and dissection in cold KRBS will block the pump, causing rundown of ionic gradients. In previous studies (32), we have shown that rewarming the coronary artery after prolonged cold exposure leads to an initial period of hyperpolarization due to sodium pump stimulation, followed by return of E m to a less polarized value after ϳ1.5-2 h. A similar transient hyperpolarization can occur when sodium pump activity is blocked by removing potassium from the bathing solution for 30 min and then returning potassium (31) . Since active tone is dependent on Ca v activity and Ca v activity is E m dependent, it is possible that tone is suppressed during the initial recovery period because of pump stimulation.
Role of PKC and Ca v in active tone development. Numerous studies (2, 10, 15, 18, 22, 26, 37, 39, 45, 52, 64) have suggested that PKC activity contributes to myogenic tone in microvessels. PKC can cause smooth muscle contraction via a number of different pathways, including 1) changes in ionic conductance that depolarize E m , leading to an increase in Ca v activity (12, 19, 52) ; 2) direct stimulation of Ca v (6, 8, 57) ; and 3) increased sensitivity of the myofilaments to Ca 2ϩ (15, 18, 39) . In coronary artery, chelerythrine reversed active tone development and caused repolarization. This suggests that PKC activity was elevated during active tone development and that the actions of PKC were due in part to effects on E m (i.e., mechanism 1). Myogenic tone has also been attributed in part to depolarization, which will enhance Ca v activity (12, 20, 21, 34, 38, 52) . Interestingly, myogenic depolarization of rat cerebral arteries is also blocked by chelerythrine (52) . This study suggested that PKC activates transient receptor potential channels that depolarize cells, leading to enhanced Ca v activity, Ca 2ϩ entry, and contraction. It is possible that a similar mechanism contributes to active tone in the rabbit coronary artery. Alternatively, depolarization may involve some other ionic conductance such as delayed-rectifier potassium channels, which are blocked by PKC (12, 13) .
Active tone exhibited a number of properties in common with the contraction that developed with the PKC activator PDBu (10 nM). Both contractions were antagonized to the same extent by three different PKC blockers as well as by the Ca v blocker nifedipine. Interestingly, we observed that the classical PKC antagonist Gö-6976 was an effective antagonist of both types of contraction, suggesting that it is a classical PKC in particular that participates in active tone development and the response to 10 nM PDBu.
Regulation of Ca v currents by PKC. In addition to causing relaxation and repolarization, the PKC inhibitor chelerythrine also shifted the relationship between E m and contraction to the right, suggesting that PKC modulates tone in part via mechanisms that do not require a change in E m . One such mechanism investigated in this study was the direct effects of PKC on Ca v . Activation of PKC via PDBu led to a significant increase in Ca v current, which was reversed by either chelerythrine or the classical PKC inhibitor Gö-6976. This is the first time a PKC activator has been shown to directly stimulate Ca v currents in a coronary myocyte, although PKC activators have been reported to enhance Ca v currents in several other smooth muscles (6, 8, 57) . Previous studies using PKC inhibitors also suggest that PKC can directly enhance Ca v currents in coronary artery (37, 43) . The ability of Gö-6976 to reverse the effect of PDBu is interesting because it suggests that a classical PKC in particular underlies current stimulation. Thus our contractile studies implicate Ca v and classical PKCs in active tone development, and our patch clamp studies suggest that classical PKCs enhance Ca v currents. Therefore, we propose that active tone is regulated in part via the direct effects of classical PKCs on Ca v currents. In studies of the rabbit basilar artery, stretchinduced contraction was specifically attributed to the classical PKC-␣ (64). In addition, in cerebral artery myocytes PKC-␣ has been shown to promote clusters of Ca v channels to operate in a persistent gating mode (46, 47) , providing a possible mechanism by which classical PKCs may enhance Ca v currents in rabbit coronary artery myocytes.
In conclusion, our results suggest that the regulation of active tone in the coronary artery involves a balance between factors that either favor or oppose contraction (Fig. 10) . Both PKC and NO participate in this regulation, and Ca v activity is an important (although not exclusive) target. When the endothelium is intact, the balance favors the quiescent vessel. In contrast, when NOS activity is blocked, the balance shifts toward active tone development. Finally, the quiescent state can be restored if either NO is replaced or PKC activity is blocked. In the healthy coronary artery, the balance of factors favors quiescence. However, in various cardiovascular disease states there is reduced bioavailability of NO (24) . Under these conditions, the balance is predicted to shift toward active tone development. Indeed, vasospasm is more prevalent in diseased coronary arteries, and this type of activity can give rise to ischemia, myocardial infarction, and sudden death (36) . Thus understanding the mechanisms that underlie active tone development in the coronary artery and the role that NO plays in this process is important to understanding both the normal function of this vessel and the changes that may occur with cardiovascular disease.
